Well said, LL1truth. I share the same sentiment here and you just reminded me of another important point in the grand scheme of BMSN/Regen.
Notice the following statement from the last PR (May 12, 2014):
On March 6, 2014, Regen submitted a protocol modification, additional details on manufacturing, and new data to the FDA regarding therapeutic effects of HemaXellerate I™ in animal models of diseases similar to aplastic anemia in humans, as well as additional safety data.
My thinking around this March 6th coincidence is that Koos may be trying to juggle HemaXellerate, FDA, FINRA, and potentially dCellVax (IND) timelines such that they positively align around the Regen IPO. It can't be an easy task to orchestrate since he is not in control of every response (i.e., FDA and FINRA turn around times), but it looks like we're building to something big this summer. As you said, this would be huge, and clearly a great way to attract big money to BMSN and Regen.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.